30
Mar

The largest breast AI study to date shows value of Transpara in mammographic screening

The largest breast AI study to date shows value of Transpara in mammographic screening
In a recent study, the Cancer Registry of Norway used over 120,000 screening examinations from a population-based program to assess potential of using AI in screening. The study, published in Radiology, looked at 122,969 screening examinations from 47,877 women performed at four facilities of BreastScreen Norway.

Read the release here